- Release Date: 07/10/21 08:27
- Summary: MAYNE PHARMA provides FDA update on generic NUVARING
- Price Sensitive: No
- Download Document 142.82KB
Ann: MAYNE PHARMA provides FDA update on generic NUVARING
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.20 |
Change
0.100(1.96%) |
Mkt cap ! $442.3M | |||
| Open | High | Low | Value | Volume |
| $5.10 | $5.25 | $4.91 | $1.081M | 212.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 299 | $5.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.25 | 17476 | 8 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MYX (ASX) Chart |